Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oncogene ; 37(40): 5416-5434, 2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-29867202

RESUMO

Tumor metastasis is the most common cause of cancer death. Elucidation of the mechanism of tumor metastasis is therefore important in the development of novel, effective anti-cancer therapies to reduce cancer mortality. Interaction between cancer cells and surrounding stromal cells in the tumor microenvironment is a key factor in tumor metastasis. Using a co-culture assay system with human prostate cancer LNCaP cells and primary human prostate stromal cells, we identified epithelial membrane protein 1 (EMP1) as a gene with elevated expression in the cancer cells. The orthotopic injection of LNCaP cells overexpressing EMP1 (EMP1-LNCaP cells) into the prostate of nude mice induced lymph node and lung metastases, while that of control LNCaP cells did not. EMP1-LNCaP cells had higher cell motility and Rac1 activity than control LNCaP cells. These results were also observed in other lines of cancer cells. We newly identified copine-III as an intracellular binding partner of EMP1. Knockdown of copine-III attenuated the increased cell motility and Rac1 activity in EMP1-LNCaP cells. Reduced cell motility and Rac1 activity following knockdown of copine-III in EMP1-LNCaP cells were recovered by re-expression of wild-type copine-III, but not of a copine-III mutant incapable of interacting with EMP1, suggesting the importance of the EMP1-copine-III interaction. Phosphorylated and activated Src and a Rac guanine nucleotide exchange factor Vav2 were found to be involved in the EMP1-induced enhancement of cell motility and Rac1 activation. Moreover, EMP1 was highly expressed in prostate cancer samples obtained from patients with higher Gleason score. These results demonstrate that upregulation of EMP1 significantly increases cancer cell migration that leads to tumor metastasis, suggesting that EMP1 may play an essential role as a positive regulator of tumor metastasis.


Assuntos
Movimento Celular , Proteínas de Neoplasias/metabolismo , Fosfoproteínas/metabolismo , Receptores de Superfície Celular/metabolismo , Proteínas rac1 de Ligação ao GTP/metabolismo , Linhagem Celular Tumoral , Progressão da Doença , Humanos , Invasividade Neoplásica , Metástase Neoplásica , Transdução de Sinais , Células Estromais/patologia , Regulação para Cima
2.
Cancer Res ; 77(21): 6001-6010, 2017 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-28882998

RESUMO

Immune surveillance is a critical component of the antitumor response in vivo, yet the specific components of the immune system involved in this regulatory response remain unclear. In this study, we demonstrate that autoantibodies can mitigate tumor growth in vitro and in vivo We generated two cancer cell lines, embryonal carcinoma and glioblastoma cell lines, from monkey-induced pluripotent stem cells (iPSC) carrying a homozygous haplotype of major histocompatibility complex (MHC, Mafa in Macaca fascicularis). To establish a monkey cancer model, we transplanted these cells into monkeys carrying the matched Mafa haplotype in one of the chromosomes. Neither Mafa-homozygous cancer cell line grew in monkeys carrying the matched Mafa haplotype heterozygously. We detected in the plasma of these monkeys an IgG autoantibody against GRP94, a heat shock protein. Injection of the plasma prevented growth of the tumor cells in immunodeficient mice, whereas plasma IgG depleted of GRP94 IgG exhibited reduced killing activity against cancer cells in vitro These results indicate that humoral immunity, including autoantibodies against GRP94, plays a role in cancer immune surveillance. Cancer Res; 77(21); 6001-10. ©2017 AACR.


Assuntos
Autoanticorpos/imunologia , Proteínas de Choque Térmico HSP70/imunologia , Células-Tronco Pluripotentes Induzidas/imunologia , Complexo Principal de Histocompatibilidade/imunologia , Proteínas de Membrana/imunologia , Neoplasias/imunologia , Animais , Autoanticorpos/sangue , Autoanticorpos/metabolismo , Carcinoma Embrionário/genética , Carcinoma Embrionário/imunologia , Carcinoma Embrionário/patologia , Linhagem Celular Tumoral , Células Cultivadas , Feminino , Glioblastoma/genética , Glioblastoma/imunologia , Glioblastoma/patologia , Proteínas de Choque Térmico HSP70/genética , Proteínas de Choque Térmico HSP70/metabolismo , Haplótipos , Homozigoto , Células-Tronco Pluripotentes Induzidas/metabolismo , Macaca fascicularis , Complexo Principal de Histocompatibilidade/genética , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Camundongos , Transplante de Neoplasias/métodos , Neoplasias/genética , Neoplasias/patologia
3.
J Atheroscler Thromb ; 21(8): 839-53, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24717759

RESUMO

AIM: Mutations in lipoprotein-associated phospholipase A2 (Lp-PLA2) are related to atherosclerosis. However, the molecular effects of Lp-PLA2 on atherosclerosis have not been fully investigated. Therefore, this study attempted to elucidate this issue. METHODS: Monocytes were isolated from randomly selected healthy male volunteers according to each Lp-PLA2 genotype (wild-type Lp-PLA2 [Lp-PLA2 (V/V)], the heterozygous V279F mutation [LpPLA2 (V/F)] and the homozygous V279F mutation [Lp-PLA2 (F/F)]) and differentiated into macrophages. The level of apoptosis in the macrophages following incubation without serum was measured using the annexin V/propidium iodide double staining method, and the underlying mechanisms were further examined using a culture cell line. RESULTS: The average plasma Lp-PLA2 concentration [Lp-PLA2 (V/V): 129.4 ng/mL, Lp-PLA2 (V/F): 70.7 ng/mL, Lp-PLA2 (F/F): 0.4 ng/mL] and activity [Lp-PLA2 (V/V): 164.3 nmol/min/mL, LpPLA2 (V/F): 100.9 nmol/min/mL, Lp-PLA2 (F/F): 11.6 nmol/min/mL] were significantly different between each genotype, although the basic clinical characteristics were similar. The percentage of apoptotic cells was significantly higher among the Lp-PLA2 (F/F) macrophages compared with that observed in the Lp-PLA2 (V/V) macrophages. This induction of apoptosis was independent of the actions of acetylated low-density lipoproteins. In addition, the transfection of the expression plasmid of V279F mutant Lp-PLA2 into Cos-7 cells or monocyte/macrophage-like U937 cells promoted apoptosis. The knockdown of Lp-PLA2 also increased the number of apoptotic cells. Among the cells expressing mutant Lp-PLA2, the caspase-7 activity was increased, while the activated Akt level was decreased. CONCLUSIONS: The V279F mutation of Lp-PLA2 positively regulates the induction of apoptosis in macrophages and Cos-7 cells. An increase in the caspase-7 activity and a reduction in the activated Akt level are likely to be involved in this phenomenon.


Assuntos
1-Alquil-2-acetilglicerofosfocolina Esterase/genética , Apoptose , Caspase 7/metabolismo , Macrófagos/patologia , Mutação/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , 1-Alquil-2-acetilglicerofosfocolina Esterase/metabolismo , Adulto , Idoso , Animais , Western Blotting , Células COS , Proliferação de Células , Células Cultivadas , Chlorocebus aethiops , Citometria de Fluxo , Heterozigoto , Humanos , Lipoproteínas LDL/metabolismo , Macrófagos/metabolismo , Masculino , Pessoa de Meia-Idade , Monócitos/metabolismo , Monócitos/patologia , Reação em Cadeia da Polimerase em Tempo Real
4.
Biochem Biophys Res Commun ; 427(3): 497-502, 2012 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-23000411

RESUMO

High molecular weight kininogen (HK) is a plasma glycoprotein with multiple functions, including the regulation of coagulation. We previously demonstrated that domain 5 (D5(H)), a functional domain of HK, and its derived peptides played an important role in the vitronectin-mediated suppression of cancer cell adhesion and invasion. However, the underlying mechanisms of the D5(H)-mediated suppressive effects remain to be elucidated. Here, we showed that D5(H) and its derivatives inhibited the collagen-mediated cell adhesion and invasion of human osteosarcoma MG63 cells. Using purified D5(H) fused to glutathione-S-transferase (GST) and D5(H)-derived peptides for column chromatography, an actin-binding protein, α-actinin-4, was identified as a binding protein of D5(H) with high-affinity for P-5m, a core octapeptide of D5(H). Immunofluorescence microscopy demonstrated that D5(H) co-localized with α-actinin-4 inside MG63 cells. In addition, exogenous GST-D5(H) added to the culture media was transported into MG63 cells, although GST alone as a control was not. As α-actinin-4 regulates actin polymerization necessary for cell adhesion and is related to the integrin-dependent attachment of cells to the extracellular matrix, our results suggest that D5(H) may modulate cell adhesion and invasion together with actinin-4.


Assuntos
Actinina/metabolismo , Cininogênio de Alto Peso Molecular/metabolismo , Neoplasias/patologia , Sequência de Aminoácidos , Adesão Celular , Linhagem Celular Tumoral , Colágeno/metabolismo , Humanos , Cininogênio de Alto Peso Molecular/genética , Cininogênio de Alto Peso Molecular/farmacologia , Dados de Sequência Molecular , Invasividade Neoplásica , Neoplasias/metabolismo , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/metabolismo , Fragmentos de Peptídeos/farmacologia
5.
Biochem Biophys Res Commun ; 423(4): 690-6, 2012 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-22699120

RESUMO

Phosphatidylethanolamine-binding proteins (PEBPs) are found in various species and have multiple functions. In this study, we purified the swine homolog of human PEBP4 (sPEBP4) from swine seminal plasma, cloned the sPEBP4 cDNA and functionally characterized this protein. The molecular mass of the purified protein was calculated to be 25 kDa by SDS-polyacrylamide gel electrophoresis under reducing conditions. The full-length cDNA of sPEBP4 contains 815 bp with an open reading frame of 669 bp that encodes a protein 222 residues in length. sPEBP4 contains a putative phosphatidylethanolamine-binding domain between residues 79 and 195; however, this domain did not show lipid binding activity. The overall amino acid sequence identity of PEBP4s from swine, human, mouse, bovine and canine ranges between 56.1% and 82.4%. Immunohistochemical staining and western blotting analysis showed that sPEBP4 is secreted from epithelial cells in the epididymis to the seminal plasma. To explore the role of sPEBP4 in the seminal plasma, we tested the effect of sPEBP4 on swine sperm motility. Sperms suspended in phosphate-buffered saline began to swim after the addition of purified sPEBP4, but not when swine serum albumin was added, indicating that sPEBP4 promotes sperm motility.


Assuntos
Proteína de Ligação a Fosfatidiletanolamina/isolamento & purificação , Proteína de Ligação a Fosfatidiletanolamina/metabolismo , Sêmen/metabolismo , Suínos/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Gatos , Bovinos , Clonagem Molecular , Cães , Epididimo/metabolismo , Humanos , Masculino , Camundongos , Dados de Sequência Molecular , Proteína de Ligação a Fosfatidiletanolamina/genética , Fosfolipídeos/metabolismo , Motilidade dos Espermatozoides , Suínos/genética , Testículo/metabolismo
6.
PLoS One ; 7(5): e37220, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22623997

RESUMO

We made an H1N1 vaccine candidate from a virus library consisting of 144 ( = 16 HA×9 NA) non-pathogenic influenza A viruses and examined its protective effects against a pandemic (2009) H1N1 strain using immunologically naïve cynomolgus macaques to exclude preexisting immunity and to employ a preclinical study since preexisting immunity in humans previously vaccinated or infected with influenza virus might make comparison of vaccine efficacy difficult. Furthermore, macaques carrying a major histocompatibility complex class I molecule, Mafa-A1*052:02, were used to analyze peptide-specific CD8(+) T cell responses. Sera of macaques immunized with an inactivated whole particle formulation without addition of an adjuvant showed higher neutralization titers against the vaccine strain A/Hokkaido/2/1981 (H1N1) than did sera of macaques immunized with a split formulation. Neutralization activities against the pandemic strain A/Narita/1/2009 (H1N1) in sera of macaques immunized twice with the split vaccine reached levels similar to those in sera of macaques immunized once with the whole particle vaccine. After inoculation with the pandemic virus, the virus was detected in nasal samples of unvaccinated macaques for 6 days after infection and for 2.67 days and 5.33 days on average in macaques vaccinated with the whole particle vaccine and the split vaccine, respectively. After the challenge infection, recall neutralizing antibody responses against the pandemic virus and CD8(+) T cell responses specific for nucleoprotein peptide NP262-270 bound to Mafa-A1*052:02 in macaques vaccinated with the whole particle vaccine were observed more promptly or more vigorously than those in macaques vaccinated with the split vaccine. These findings demonstrated that the vaccine derived from our virus library was effective for pandemic virus infection in macaques and that the whole particle vaccine conferred more effective memory and broader cross-reactive immune responses to macaques against pandemic influenza virus infection than did the split vaccine.


Assuntos
Genes MHC Classe I/genética , Memória Imunológica/imunologia , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza/imunologia , Infecções por Orthomyxoviridae/prevenção & controle , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/sangue , Temperatura Corporal , Cromatografia Líquida , Citocinas/imunologia , Primers do DNA/genética , DNA Complementar/genética , Ensaio de Imunoadsorção Enzimática , Genes MHC Classe I/imunologia , Macaca fascicularis , Dados de Sequência Molecular , Testes de Neutralização , Reação em Cadeia da Polimerase , Espectrometria de Massas em Tandem , Transfecção
7.
J Biol Chem ; 285(3): 2184-92, 2010 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-19920146

RESUMO

We found that factor H (FH) exists in porcine seminal plasma. Purified FH strongly inhibited serum alternative pathway complement activation against lipopolysaccharide. The molecular weight, pI, and heparin-binding activity of the purified protein were different from those of purified FH from porcine serum. The complement regulatory activity of seminal plasma FH was approximately 2-fold stronger than that of serum FH. Treatment of purified serum FH with sialidase and N-glycosidase F gave almost the same results as those of seminal plasma FH. The deletion of sialic acid from the carbohydrate chains of both FHs contributed to heparin-binding and complement regulatory activities. Results of reverse transcriptase-PCR, Western blot analysis, and immunohistochemistry showed that seminal plasma FH is mainly secreted from epithelial cells of the seminal vesicle in male genital tracts. FH was also detected in the outer acrosomal region of ejaculated sperm by immunofluorescence staining, and found that the purified FH from the sperm membrane has the same complement regulatory activity as that of seminal plasma FH. The ejaculated sperm possessing FH in the outer acrosomal region considerably evaded complement attack. We also found that there is strong complement activity in fluids from female genital tract ducts. These findings indicate that FH bound to the outer acrosomal region and soluble FH play important roles in protecting sperm against complement attack in male and female genital tracts.


Assuntos
Fator H do Complemento/imunologia , Fator H do Complemento/metabolismo , Proteínas do Sistema Complemento/imunologia , Genitália Feminina/imunologia , Sêmen/metabolismo , Espermatozoides/imunologia , Suínos , Animais , Membrana Celular/metabolismo , Ativação do Complemento , Fator H do Complemento/química , Fator H do Complemento/isolamento & purificação , Complexo de Ataque à Membrana do Sistema Complemento/imunologia , Complexo de Ataque à Membrana do Sistema Complemento/metabolismo , Via Alternativa do Complemento , Ejaculação , Epididimo/citologia , Epididimo/metabolismo , Feminino , Regulação da Expressão Gênica , Glicosídeo Hidrolases/metabolismo , Heparina/metabolismo , Concentração de Íons de Hidrogênio , Masculino , Camundongos , Peso Molecular , Transporte Proteico , Testículo/citologia , Testículo/metabolismo
8.
FEBS Lett ; 581(7): 1417-24, 2007 Apr 03.
Artigo em Inglês | MEDLINE | ID: mdl-17350006

RESUMO

Legumain/asparaginyl endopeptidase (EC 3.4.22.34) is a novel cysteine protease that is abundantly expressed in the late endosomes and lysosomes of renal proximal tubular cells. Recently, emerging evidence has indicated that legumain might play an important role in control of extracellular matrix turnover in various pathological conditions such as tumor growth/metastasis and progression of atherosclerosis. We initially found that purified legumain can directly degrade fibronectin, one of the main components of the extracellular matrix, in vitro. Therefore, we examined the effect of legumain on fibronectin degradation in cultured mouse renal proximal tubular cells. Fibronectin processing can be inhibited by chloroquine, an inhibitor of lysosomal degradation, and can be enhanced by the overexpression of legumain, indicating that fibronectin degradation occurs in the presence of legumain in lysosomes from renal proximal tubular cells. Furthermore, in legumain-deficient mice, unilateral ureteral obstruction (UUO)-induced renal interstitial protein accumulation of fibronectin and renal interstitial fibrosis were markedly enhanced. These findings indicate that legumain might have an important role in extracellular matrix remodeling via the degradation of fibronectin in renal proximal tubular cells.


Assuntos
Cisteína Endopeptidases/fisiologia , Matriz Extracelular/enzimologia , Fibronectinas/metabolismo , Nefropatias/enzimologia , Túbulos Renais Proximais/enzimologia , Animais , Células Cultivadas , Cisteína Endopeptidases/química , Cisteína Endopeptidases/genética , Matriz Extracelular/patologia , Fibronectinas/química , Fibrose , Nefropatias/patologia , Túbulos Renais Proximais/citologia , Túbulos Renais Proximais/patologia , Camundongos , Camundongos Mutantes
9.
Int J Biochem Cell Biol ; 38(4): 521-32, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16324874

RESUMO

Manganese-superoxide dismutase was purified to homogeneity from scallop adductor muscle using DEAE-Sephacel, Buthyl-Cellulofine and Superdex 200 pg column chromatographies. The molecular weights of the purified enzyme were calculated to be 22,321.4 according to time-of-flight mass spectrometry, and to be approximately 95,000 and 93,000 on Superdex 200 pg column chromatography and non-denatured PAGE, respectively, and were calculated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to be 24,000 and 25,000 in the absence and 25,000 in the presence of beta-mercaptoethanol. These findings suggested that the native enzyme is composed of four identical subunits. Other properties of scallop adductor muscle manganese-superoxide dismutase, including pH stability and heat stability, were also determined. We determined the partial amino acid sequences of purified manganese-superoxide dismutase using digestions by bromocyan and lysyl endopeptidase and also determined the manganese-superoxide dismutase cDNA structure. The amino acid sequence of the enzyme obtained using both methods showed homology to those of vertebrates such as human, bovine, chicken, Xenopus and zebrafish manganese-superoxide dismutases (64.91, 65.35, 64.47, 63.27 and 64.60%, respectively). We also predicted the 3D structure of scallop adductor muscle manganese-superoxide dismutase using molecular operating environment and compared its structure with those of other manganese-superoxide dismutases. The overall structure of scallop adductor muscle manganese-superoxide dismutase was very similar to those of other species, including human and Aspergillus.


Assuntos
Pectinidae/enzimologia , Superóxido Dismutase/química , Sequência de Aminoácidos , Animais , Humanos , Dados de Sequência Molecular , Pectinidae/genética , Estrutura Terciária de Proteína , Análise de Sequência de Proteína , Homologia de Sequência de Aminoácidos , Superóxido Dismutase/genética , Superóxido Dismutase/isolamento & purificação
10.
Oncol Rep ; 12(5): 1071-7, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15492795

RESUMO

90K/Mac-2 Binding Protein (M2BP) plays a role in regulation of immune responses and cell adhesive ability in patients with cancer and infectious diseases. We previously reported that M2BP was highly expressed in lung cancer and that immune responses to M2BP were increased in many patients with lung cancer. To determine the involvement of M2BP in metastatic processes of cancer progression, we examined the ability of M2BP DNA-transduced lung carcinoma cell lines to adhere to extracellular matrices. Although expressions of cell-surface integrins were not modulated in the M2BP transfectants, they showed increased adhesiveness to fibronectin and collagen IV. We next analyzed the serum levels of M2BP in patients with lung cancer and normal donors and the relationships between M2BP expression and clinicopathological factors in the patients. The M2BP level was markedly elevated in the patients and was strongly correlated with nodal involvement and clinical staging. To determine whether expression of M2BP by cancer cells is modulated in the environment of tumor-bearing hosts, M2BP expression in M2BP-positive QG56 cells following exposure of the cells to pro-inflammatory cytokines was examined. The M2BP expression in QG56 cells was up-regulated by many of the cytokines that activate host protective immunity. The findings in this study suggest that M2BP plays a role in cancer metastasis by increased adhesiveness of cancer cells and that M2BP is increasingly produced even in a state of exposure to the host immune system. This molecule may be useful as a predictive factor of disease progression in lung cancer.


Assuntos
Adenocarcinoma/metabolismo , Proteínas de Transporte/metabolismo , Glicoproteínas/metabolismo , Neoplasias Pulmonares/metabolismo , Adenocarcinoma/secundário , Adesividade , Idoso , Antígenos de Neoplasias , Biomarcadores Tumorais , Northern Blotting , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/secundário , Proteínas de Transporte/genética , Estudos de Casos e Controles , Adesão Celular , Colágeno Tipo IV/metabolismo , Citocinas/farmacologia , Matriz Extracelular/metabolismo , Feminino , Fibronectinas/metabolismo , Glicoproteínas/genética , Humanos , Neoplasias Pulmonares/patologia , Masculino , Células Tumorais Cultivadas
11.
J Biol Chem ; 278(49): 49301-7, 2003 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-14506238

RESUMO

We have demonstrated previously that kinin-free high molecular weight kininogen, its domain 5 (D5H, Gly402-Lys502), and peptides derived from D5H inhibited vitronectin-mediated migration and invasion of cancer cells in vitro (Kamiyama, F., Maeda, T., Yamane, T., Li, Y. H., Ogikubo, O., Otsuka, T., and Ohkubo, I. (2001) Biochem. Biophys. Res. Commun. 288, 975-980). In this study, we found that the amino acid sequence His-Gly-Lys (HGK) in D5H is the core motif for inhibition of adhesion and invasion of MDA-MB-231 cells in vitro. P-5m (484GHGKHKNK491, Gly484-Lys491), an octapeptide including the HGK motif derived from D5H, and HGK, a tripeptide, inhibited both cell adhesion and invasion in vitro. However, an octapeptide designated P-5m (K487R), in which Lys487 was changed to Arg, did not inhibit either cell adhesion or invasion, and peptides HGR and HGG also had no inhibitory effect. Recombinant GST-D5H expressed in Escherichia coli had a stronger inhibitory effect on cell adhesion and invasion in vitro than did GST-D5H (K487R) in which Lys487 was changed to Arg. Furthermore, P-5m (Gly484-Lys491) peptide clearly suppressed lung metastasis in mice experimentally induced by using B16-F10 cells, but P-5m (G487R) had no effect. These data strongly indicate that both the HGK motif and lysine residue (Lys487) play essential roles in inhibition of cell adhesion and invasion in vitro and in prevention of metastasis of cancer cells in vivo. We tried to identify the HGK motif binding protein on the surface of cancer cells. A 95-kDa surface biotin-labeled membrane protein was specifically detached from GST-D5H by P-5 (His479-Lys493) peptide but not by P-1 (Gly402-Lys420) peptide originating from the N-terminal region of D5H.


Assuntos
Motivos de Aminoácidos , Cininogênio de Alto Peso Molecular/química , Metástase Neoplásica , Oligopeptídeos/fisiologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Adesão Celular/fisiologia , Linhagem Celular Tumoral , Primers do DNA , Endotélio Vascular/citologia , Endotélio Vascular/metabolismo , Humanos , Camundongos , Dados de Sequência Molecular , Invasividade Neoplásica
12.
Cancer Gene Ther ; 9(4): 330-7, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11960283

RESUMO

In order to induce specific antitumor immunity in mice, we attempted to immunize C57BL/6 mice with DNA vaccine encoding MUC1 polypeptide. When the mice immunized with MUC1 DNA were challenged with EL4-muc, MUC1-transfected syngeneic lymphoma cells, they completely rejected tumors. When DNA vaccine was given to the EL4-muc tumor-bearing mice, this vaccination was insufficient to suppress tumor growth in the mice. However, activated, but nonprimed dendritic cells (DCs) obtained from syngeneic mice and MUC1 DNA vaccine were given simultaneously to the same site of EL4-muc tumor-bearing mice, tumor growth was markedly suppressed accompanying prolongation of survival time. MUC1 antigen was detected on the DCs at the vaccination site and in regional nodes in the mice which received MUC1 DNA vaccine and DCs. These mice showed markedly enhanced cellular immune responses specific for MUC1 compared to those in mice vaccinated with MUC1 DNA alone. No significant difference in titers of antibodies to MUC1 between the two groups was observed. These results suggest that nonprimed DCs inoculated at the DNA vaccine site are essential for eliciting strong antitumor cellular immunity to suppress tumor growth efficiently in DNA-vaccinated mice. This animal model is useful for developing DNA vaccine for anti-cancer immunotherapy.


Assuntos
Células Dendríticas/imunologia , Imunoterapia/métodos , Mucina-1/genética , Mucina-1/imunologia , Neoplasias Experimentais/imunologia , Neoplasias Experimentais/prevenção & controle , Vacinas de DNA/administração & dosagem , Animais , Formação de Anticorpos , Antígenos CD/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunidade Celular , Injeções Subcutâneas , Linfoma/prevenção & controle , Camundongos , Camundongos Endogâmicos C57BL , Linfócitos T/imunologia , Transfecção , Células Tumorais Cultivadas , Vacinação/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...